PRNT Holdings of Conformis (CFMS) - Updated Daily

Join Premium Plan

Shares HeldWeight In Fund

The PRNT ETF is not an actively managed fund. There are no daily trades and the weighting is indexed to the Total 3D-Printing Index. The holdings heres are therefore considered outside the normal analysis for Cathie's Ark. However, the fund and Total 3D-Printing Index are still run by Ark Investment so it's worth paying attention to.

Key Statistics

Statistics

🕵🏼Found In	🏷Last Price
PRNT	$0.69
⚖️Weighting	🧢Market Cap
3.02%	$128.04m
🏋🏿‍♂️Weight Rank In PRNT	🧮Price to Sales
17	1.28
💳ARK Estimated Cost Average	🌏Country
	🇺🇸United States
🎫ARK Ownership Percent
7.02%

Description
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Website
www.conformis.com

Research Notes and Commentary for CFMS

No Research Notes Found for CFMS